Clinical Trial: Clinical Study Evaluating the Safety and Efficacy of IC19 CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus

U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06886919) titled 'Clinical Study Evaluating the Safety and Efficacy of IC19 CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus' on March 14.

Brief Summary: This study is an open label, single arm exploratory clinical trial of IC19 CAR-T cell therapy for refractory systemic lupus erythematosus. Patients who are still in an active state after systemic treatment using the standard treatment regimen specified in the treatment guidelines were selected to receive IC19 CAR-T cell single pulse infusion therapy.

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Difficult to Treat Systemic Lupus Erythematosus

Intervention: BIO...